Ask AI
ProCE Banner Series

Expert Insights on the Most Practice-Changing Evidence for CAR T-Cell Therapy Across Hematologic Malignancies

Tune in to this live webinar to gain expert insights into the latest CAR T-cell therapy data for lymphomas, leukemias, and multiple myeloma from recent conferences, including SOHO, ICML, EHA, and ASCO.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This educational activity is intended for hematologists, oncologists, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with leukemia, lymphoma, or multiple myeloma eligible for CAR T-cell therapy.

All Events

Expert Insights on the Most Practice-Changing Evidence for CAR T-Cell Therapy Across Hematologic Malignancies

Upcoming Events

October

29

2025

1:30 PM - 2:30 PM Eastern Time (ET)

Virtual

Topics

Hematologic malignancies
Lymphomas
Leukemias
Multiple myeloma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity's goal is to improve the knowledge and competence of learners in leveraging emerging and established CAR T-cell therapies to optimize clinical outcomes in patients with leukemia, lymphoma, or multiple myeloma.

Target Audience
This educational activity is intended for hematologists, oncologists, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with leukemia, lymphoma, or multiple myeloma eligible for CAR T-cell therapy.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Educate patients and colleagues on the scientific rationales and clinical needs behind new approaches to CAR T-cell therapy in treatment of hematologic malignancies
  • Develop individualized treatment plans leveraging approved CAR T-cell therapies to optimize clinical outcomes in patients with hematologic malignancies based on the latest clinical evidence
  • Apply the most recent real-world and clinical trial data on CAR T-cell therapies to mitigate toxicity risk and support quality of life for patients with hematologic malignancies
  • Evaluate emerging data for novel CAR T-cell therapies and the potential implications for near-future clinical management of patients with hematologic malignancies
  •  

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-374-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191